In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II

TAS‐103 is a novel anticancer agent targeting both topoisomerase (Topo) I and Topo II, that stabilizes cleavable complexes of Topo‐DNA at the cellular level. In this study, the in vitro antitumor effects of TAS‐103 were compared with those of other known Topo I and Topo II inhibitors. TAS‐103 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyagi, Yoshimi, Kobunai, Takashi, Utsugi, Teruhiro, Oh‐hara, Tomoko, Yamada, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1999
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926096/
https://www.ncbi.nlm.nih.gov/pubmed/10391099
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00786.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926096/
https://www.ncbi.nlm.nih.gov/pubmed/10391099
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00786.x

Ejemplares similares